Deep dives into and analysis of issues that impact access to medicines.
Our views on what governments and the international community can do to fight this pandemic and prepare for the next one.
Timely and topical analysis on the day-to-day issues in intellectual property and health.
Instances when authorities have invoked, planned to/were asked to invoke a flexibility contained in the TRIPS Agreement for public health reasons.
Tools to help governments and others looking to increase access to medicines by using flexibilities in intellectual property law.
Learn about Medicines Law & Policy's team of legal and policy experts.
Deep dives into and analysis of issues that impact access to medicines.
Our views on what governments and the international community can do to fight this pandemic and prepare for the next one.
Timely and topical analysis on the day-to-day issues in intellectual property and health.
Instances when authorities have invoked, planned to/were asked to invoke a flexibility contained in the TRIPS Agreement for public health reasons.
Tools to help governments and others looking to increase access to medicines by using flexibilities in intellectual property law.
Learn about Medicines Law & Policy's team of legal and policy experts.
Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at:Â office@medicineslawandpolicy.net.
This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.
Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at:Â office@medicineslawandpolicy.net.
This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.